Evidence map›Paper›PMID 39435610›Full record

ArticleGlia2025

Three-dimensional view of microglia-amyloid plaque interactions.

Maria Gotkiewicz, Janne Capra, Pasi O Miettinen, Teemu Natunen, Heikki Tanila

Abstract read
In one paragraph

Article in Glia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Microglial phagocytosis in Alzheimer disease.Nature reviews. Neurology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria GotkiewiczUniversity of Eastern Finland, A.I. Virtanen Institute, Kuopio, Finland.
Janne CapraInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Pasi O MiettinenUniversity of Eastern Finland, A.I. Virtanen Institute, Kuopio, Finland.
Teemu NatunenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Heikki TanilaUniversity of Eastern Finland, A.I. Virtanen Institute, Kuopio, Finland.ORCID 0000-0001-8579-7562

Funding

Finnish Cultural FoundationSuomen KulttuurirahastoUniversity of Eastern Finland (Doctoral Programme for Molecular Medicine)
6 · The paper itself

Abstract

Recent gene expression studies have revealed about 10 different states of microglia, some of which are characteristic for Alzheimer-like amyloid plaque pathology. However, it is not presently known how these translate into morphological features that would reflect microglia interaction with amyloid plaques. With optimized conditions for confocal microscopy in amyloid plaque forming APP/PS1 transgenic mice we reveal new details of how microglia processes interact with amyloid plaques. The microglia contacts differed drastically between purely diffuse plaque and those with a fibrillar core. We identified microglia that extend their enlarged processes through the diffuse shell of the amyloid plaques and cover the fibrillar plaque core with snowplow-like expanded end-feet. These end-feet were filled with the lysosomal marker CD68, while both non-fibrillar and fibrillar amyloid was found in perinuclear vesicles of some "snowplower" microglia. In the organized dense-core plaques, we consistently saw a layer of Apolipoprotein E (ApoE) between the fibrillar core and the microglial end-feet. ApoE covered also loose fibrillar amyloid and diffuse amyloid plaques that were about 10 μm or larger in diameter. These findings are compatible with both amyloid plaque phagocytosis and compaction by microglia. Further, they support a chemotactic role of ApoE for microglia contacts with amyloid plaques.

Indexed as

Mice, TransgenicMicrogliaPlaque, AmyloidAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsAntigens, CDApolipoproteins EBrainDisease Models, AnimalHumansImaging, Three-DimensionalMiceMice, Inbred C57BLMicroscopy, ConfocalPhagocytosisAmyloid beta-Protein PrecursorAntigens, CDApolipoproteins EPresenilin-13D renderingApoEconfocal imagingdense‐core plaquetransgenic mice

Identifiers

PMID39435610
PMCPMC11660520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.